# Kailera Therapeutics (KLRA) — Analyst Forecast

KLRA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/klra/forecast

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| May 12, 2026 | JP Morgan | Initiated Coverage | Overweight | $30.00 |
| May 12, 2026 | Evercore ISI Group | Initiated Coverage | Outperform | — |
| May 12, 2026 | Jefferies | Initiated Coverage | Buy | $48.00 |
| May 12, 2026 | Leerink Partners | Initiated Coverage | Outperform | $36.00 |

## Frequently Asked Questions

### What is the latest analyst rating on KLRA?

On May 12, 2026, JP Morgan initiated coverage of Kailera Therapeutics at Overweight with a price target of $30.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).